Literature DB >> 11572328

Nongenomic action of steroids in myometrial contractility.

M Perusquía1.   

Abstract

Steroid hormones are involved in several fundamental aspects of all living beings, with a few slight chemical differences among steroids being enough to give them the extraordinarily diverse biologic specificities that are important in animal physiology and medical therapeutics. Indeed, in the uterus, they have a remarkable action on uterine contractility with physiologic significance in the important reproductive processes of mammalian pregnancy and parturition. The regulation of progesterone on the myometrial contractile activity and related wider subjects of the endocrinology of pregnancy and parturition have been reviewed many times during the twentieth century. However, new data indicate that several progesterone metabolites and some synthetic steroids induce a progesterone-like uterine-relaxing effect. Experimental evidence from our laboratory has shown that 5-reduced progestins and androgens are more potent than progesterone itself in decreasing uterine contractility. The purpose of this review is to update current knowledge of endogenous and exogenous steroids on the phenomenon of uterine contractility, by summarizing their structural differences to induce changes on this process and discussing the possible mechanism of steroids to regulate uterine muscle activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572328     DOI: 10.1385/ENDO:15:1:063

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  95 in total

1.  Experiments on the suppressive effect of a synthetic gestagen on the activity of the pregnant human uterus.

Authors:  L P BENGTSSON
Journal:  Acta Obstet Gynecol Scand       Date:  1962       Impact factor: 3.636

2.  Antagonism by 5-reduced steroids of the tonic and phasic contractions induced by serotonin in the isolated rat uterus.

Authors:  M Perusquía; G Campos; J L Corona; C Kubli-Garfias
Journal:  Proc West Pharmacol Soc       Date:  1991

3.  Temporal changes in activities of enzymes reducing ring-A of progesterone in the fetus and placenta of the rat.

Authors:  M K Sanyal; C A Villee
Journal:  Endocrinology       Date:  1976-07       Impact factor: 4.736

4.  Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma amino butyric acidA receptor systems.

Authors:  C D Putnam; D W Brann; R C Kolbeck; V B Mahesh
Journal:  Biol Reprod       Date:  1991-08       Impact factor: 4.285

5.  The inhibitory action of oestradiol-17-beta and progesterone on venous smooth muscle.

Authors:  T A McCalden
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

6.  Genomic and non-genomic effects of steroidal drugs on smooth muscle contraction in vitro.

Authors:  M Gutiérrez; V Martínez; B Cantabrana; A Hidalgo
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

7.  Vascular effects of 17 beta-estradiol in male Sprague-Dawley rats.

Authors:  J Shan; L M Resnick; Q Y Liu; X C Wu; M Barbagallo; P K Pang
Journal:  Am J Physiol       Date:  1994-03

8.  [Contraceptive activity of RU486 and oral active prostaglandin combination].

Authors:  E Aubeny; E E Baulieu
Journal:  C R Acad Sci III       Date:  1991

9.  Metabolism of 20beta-hydroxy-4-pregnen-3-one in uterine tissue of non-pregnant rats in vitro.

Authors:  B P Lisboa; M Holtermann
Journal:  Acta Endocrinol (Copenh)       Date:  1976-11

10.  Effect of oestrogen and progesterone on the blood flow in the lower urinary tract of the rabbit.

Authors:  S Batra; L Bjellin; S Iosif; L Mårtensson; C Sjögren
Journal:  Acta Physiol Scand       Date:  1985-02
View more
  6 in total

Review 1.  Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches.

Authors:  Sam A Mesiano; Gregory A Peters; Peyvand Amini; Rachel A Wilson; Gregory P Tochtrop; Focco van Den Akker
Journal:  Placenta       Date:  2019-01-28       Impact factor: 3.481

2.  Progesterone Metabolites Produced by Cytochrome P450 3A Modulate Uterine Contractility in a Murine Model.

Authors:  Avinash S Patil; Geeta K Swamy; Amy P Murtha; R Phillips Heine; Xiaomei Zheng; Chad A Grotegut
Journal:  Reprod Sci       Date:  2015-06-02       Impact factor: 3.060

3.  G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium.

Authors:  Andrei A Tica; Erica C Dun; Oana S Tica; Xin Gao; Jeffrey B Arterburn; G Cristina Brailoiu; Tudor I Oprea; Eugen Brailoiu
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-24       Impact factor: 4.249

4.  Regional differences in the vasorelaxing effects of testosterone and its 5-reduced metabolites in the canine vasculature.

Authors:  Mercedes Perusquía; Julia Espinoza; Luis M Montaño; John N Stallone
Journal:  Vascul Pharmacol       Date:  2012-02-01       Impact factor: 5.773

Review 5.  Racial disparity in infant and maternal mortality: confluence of infection, and microvascular dysfunction.

Authors:  Kevin Fiscella
Journal:  Matern Child Health J       Date:  2004-06

6.  Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.

Authors:  Mercedes Perusquía; Erika Navarrete
Journal:  Reprod Biol Endocrinol       Date:  2005-07-21       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.